Department of Genetic Engineering and Biotechnology, University of Chittagong, Chittagong, Bangladesh.
Department of Life Sciences (DLS), School of Environment and Life Sciences (SELS), Independent University, Dhaka, Bangladesh.
J Biomol Struct Dyn. 2024 Jul;42(10):5288-5307. doi: 10.1080/07391102.2023.2239921. Epub 2023 Jul 31.
A worrying new outbreak of Monkeypox (Mpox) in humans is caused by the Mpox virus (MpoxV). The pathogen has roughly 28 hypothetical proteins of unknown structure, function, and pathogenicity. Using reliable bioinformatics tools, we attempted to analyze the MpoxV genome, identify the role of hypothetical proteins (HPs), and design a potential candidate vaccine. Out of 28, we identified seven hypothetical proteins using multi-server validation with high confidence for the occurrence of conserved domains. Their physical, chemical, and functional characterizations, including molecular weight, theoretical isoelectric point, 3D structures, GRAVY value, subcellular localization, functional motifs, antigenicity, and virulence factors, were performed. We predicted possible cytotoxic T cell (CTL), helper T cell (HTL) and linear and conformational B cell epitopes, which were combined in a 219 amino acid multiepitope vaccine with human β defensin as a linker. This multi-epitopic vaccine was structurally modelled and docked with toll-like receptor-3 (TLR-3). The dynamical stability of the vaccine-TLR-3 docked complexes exhibited stable interactions based on RMSD and RMSF tests. Additionally, the modelled vaccine was cloned in an host to check the appropriate expression of the final vaccine built. Our results might conform to an immunogenic and safe vaccine, which would require further experimental validation.Communicated by Ramaswamy H. Sarma.
一种令人担忧的新型人类猴痘(Mpox)疫情是由猴痘病毒(MpoxV)引起的。该病原体大约有 28 种结构、功能和致病性未知的假设蛋白。我们使用可靠的生物信息学工具,试图分析 MpoxV 基因组,确定假设蛋白(HPs)的作用,并设计一种潜在的候选疫苗。在 28 种中,我们使用多服务器验证方法,以高置信度鉴定了 7 种具有保守结构域的假设蛋白。对其理化性质和功能特性进行了分析,包括分子量、理论等电点、3D 结构、GRAVY 值、亚细胞定位、功能基序、抗原性和毒力因子。我们预测了可能的细胞毒性 T 细胞(CTL)、辅助性 T 细胞(HTL)和线性及构象 B 细胞表位,并将其与人类β防御素作为接头结合成一个包含 219 个氨基酸的多表位疫苗。该多表位疫苗进行了结构建模,并与 Toll 样受体-3(TLR-3)对接。基于 RMSD 和 RMSF 测试,对接复合物的动力学稳定性表明了稳定的相互作用。此外,还在宿主中克隆了该疫苗,以检查构建的最终疫苗的适当表达。我们的结果可能符合一种具有免疫原性和安全性的疫苗,这将需要进一步的实验验证。由 Ramaswamy H. Sarma 传递。